| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA697619 | F | Growth inhibitory concentration of compound was measured against human melanoma cell line (HMV-1) | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 2. | ALA700036 | F | Growth inhibitory concentration of compound was measured against human leukemia cell line (K562) | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 3. | ALA704852 | F | Growth inhibitory concentration of compound was measured against human nasopharyngeal carcinoma cell line (KB) | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 4. | ALA706232 | F | Growth inhibitory concentration of compound was measured against murine leukemia cell line (L1210) | Mus musculus | 4 | cell-based format | Scientific Literature | ||
| 5. | ALA712309 | F | Growth inhibitory concentration of compound was measured against human gastric adenocarcinoma cell line (MKN-1) | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 6. | ALA753301 | F | Growth inhibitory concentration of compound was measured against DOX resistant P388 cell line (P388 /DOX) | Mus musculus | 4 | cell-based format | Scientific Literature | ||
| 7. | ALA753302 | F | Growth inhibitory concentration of compound was measured against murine leukemia cell line (P388) | Mus musculus | 4 | cell-based format | Scientific Literature | ||
| 8. | ALA857558 | F | Growth inhibitory concentration of compound was measured against human lung carcinoma cell line (PC-14) | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 9. | ALA808774 | F | Growth inhibitory concentration of compound was measured against human bladder carcinoma cell line (T24) | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 10. | ALA812286 | B | The compound was tested for its inhibitory activity against topoisomerase II | 1 | protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!